Detail
LncRNA Name | RSU1P2 |
Synonyms | RSU1P2 |
Region | GRCh38_10:45099487-45154596 Sequence |
Ensembl | ENSG00000232554 |
RefSeq | NA |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✔ |
Methylation | ✘ |
Cancer Name | cervical cancer |
ICD-0-3 | C53 |
Methods | qPCR, Western blot, Flow cytometry assay, Cell migration and invasion assay etc. |
Sample | cervical cancer tissues, cell lines (SMMC-7721 and HepG3) |
Expression Pattern | up-regulated |
Function Description | Here, we found that the lncRNA RSU1P2 is upregulateded in cervical cancer tissues and has a tumour-promoting role. We revealed that RSU1P2 acts as a ceRNA through regulating the expression of IGF1R, N-myc and EphA4. The mechanism of this regulation is via competition for the shared microRNA let-7a. This competition promotes the malignant phenotype of cervical carcinoma cells. The transcription factor N-myc forms a positive feedback loop with RSU1P2 by in turn activating its expression, thereby enhancing its oncogenic capacity. |
Pubmed ID | 27487126 |
Year | 2016 |
Title | LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells. |
External Links |
Links for RSU1P2 | GenBank HGNC lncrnadb Noncode |
Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.